Navigation Links
Research explores how breast cancer spreads and new ways to treat it
Date:8/3/2011
mmune responses capable of halting the growth of and directly killing human breast cancer cells that are resistant to trastuzumab. Duke researchers, in seeking to prepare and submit an Investigational New Drug (IND) application for the U.S. Food and Drug Administration (FDA), have demonstrated through preclinical research that the vaccine is potent, does not cause tumor development, and is compatible with lapatinib, another treatment specifically targeting HER2+ breast cancer. Both viral vectors are currently undergoing preclinical toxicology studies and are expected to enter the clinic in the third quarter of 2011.
"Patients with HER2+ breast cancer often face the reality of relapse," said Dr. Kim Lyerly of Duke University Medical Center. "We are excited about continuing this translational-based, cutting-edge vaccine strategy, and potentially bringing them a new way to fight the disease."
'/>"/>
| Contact: Dayna Hochstein dhochstein@spectrumscience.com 202-955-6222 US Department of Defense Congressionally Directed Medical Research Programs Source:Eurekalert |
Related medicine news :
1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
(Date:5/24/2013)... 2013 The Dictation Source recently added ... clients. As a result of its National marketing efforts, ... 20 states around the nation. , Since 1991, The ... to the healthcare industry . Dictation Source is owned ... years of clinical work experience to provide the solutions ...
(Date:5/24/2013)... -- The number of U.S. patients admitted to ... an emergency room has increased by nearly 50 ... conducted by researchers at the George Washington University ... Washington, D.C., found that patients wait five hours ... admitted to the ICU. The researchers said improved ...
(Date:5/24/2013)... 24, 2013 The SunglassFIX Photo ... sunglasses all while learning how to make their ... Contestants only need to upload pictures of ... "like" The Sunglass Fix on Facebook in order ... the largest lens replacement online store . ...
(Date:5/24/2013)... France: Transcatheter aortic valve implantation (TAVI) is effective and ... on first results from a multicentre Asian registry reported ... has become a treatment option for selected patients with ... all from North American or European centres," Paul Chiam, ... told the conference. He explained that it is unknown ...
(Date:5/24/2013)... In a coup that surely made other ... of the Estetica Institute of the Palm Beaches performed eye ... popular morning show, “The Mo & Sally Morning Show.” The ... satisfaction with the results, giving Dr. DeLange and the team ... Beach Gardens, very valuable free publicity. , Dr. DeLange, the ...
Breaking Medicine News(10 mins):Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:Registry confirms TAVI efficacy and safety in Asian patients 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2[0] The Dictation Source Signs Two National Hospital Chains[0] Sharp Rise in ICU Admissions From U.S. Emergency Rooms [0] Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win[0] Registry confirms TAVI efficacy and safety in Asian patients[0] Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team
... a study, the major cause of death in the Intensive ... involved are failure of central nervous system// and cardiovascular system. ... the death of patients who are out of the ICU ... cardiovascular disorder. ,This study is published in the ...
... A new study has established the wholesomeness of whole ... reducing breast cancer risk in the offspring.// ... and her colleagues examined the benefits of dietary changes ... babies’ health. These results could well mimic the occurrence ...
... that is capable of eliminating parasites that live on the ... single half hour treatment is much more efficient than// chemical ... drying up lice and their eggs blows air at a ... has been christened Louse Buster by the masterminds behind this ...
... effective primary health care for patients that was released ... other developed// countries, except the U.S. ,In ... countries, it was found that Canada lagged in several ... medical records, doctors availability after hours, multi-discipline teams for ...
... Medical Association (PMA) plans to move court against the bans ... ,"The Pakistan Cricket Board (PCB) has pleased the ... and Asif, but justice was not meted out to the ... The News Monday., ,On Wednesday, a specially constituted PCB ...
... which is likely to arouse strong feelings either way has ... in Britain - the proposal suggests mercy killing of// new ... of Obstetricians and Gynaecology put forth this recommendation as the ... lesser god" who are being kept alive because of the ...
Cached Medicine News:Health News:Lice now dried to death by novel dryer 2Health News:Consider Euthanasia For Severely Disabled Babies, College Tells Doctors 2Major causes of death in ICUs and HospitalsWhole Wheat, Wholesome for Pregnant Women and Their OffspringLice now dried to death by novel dryerLow grade for Canada in Primary Health carePakistan Medical Association To Fight For Shoaib, AsifConsider Euthanasia For Severely Disabled Babies, College Tells Doctors
(Date:5/23/2013)... 2013 TeamHealth Medical Call Center (THMCC), a ... advice lines, announces its newly formed Clinical Advisory ... administrative leaders, provides clinical expertise to advance THMCC,s ... for hospital clients, physician clients and patients. ... it,s imperative to continuously advance our services and ...
(Date:5/23/2013)... 23, 2013 More than half of women ... from chemotherapy and still have excellent outcomes. To educate ... of the largest sources of online consumer information about ... Facebook page provide recently diagnosed women with information sources, ... chemotherapy. "We anticipate these innovative social media ...
(Date:5/23/2013)... May 23, 2013 Anthem Blue Cross patients ... have required them to obtain their medications by mail ... and Whatley Kallas LLC. The lawsuit, ... that Blue Cross,s mandatory mail order program announced late ... and privacy. "This settlement brings to a ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3... Inc. today announced that the first Phase II clinical trial ... now open for enrollment. The trial is sponsored by the ... and EGEN, Inc., and is being conducted by a network ... University of Alabama at Birmingham (UAB) Hospital is the first ...
... 2010 Chimerix, Inc., a pharmaceutical ... Phase 1 clinical trial results for CMX157 demonstrating ... In addition, results from a series of preclinical ... in vitro activity against human immunodeficiency virus ...
Cached Medicine Technology:EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment 2EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment 3Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability 2Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability 3Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability 4Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability 5... Our slimmest full-featured bronchofiberscope yet. The BF-3C40's ... by 0.2mm from the previous model. It ... Olympus models, thanks to the use of ... enlarge the image size by 70 percent. ...
... designed specifically to enable direct inspection of ... for pediatric applications as well. Its insertion ... 2.8mm across. As a result, insertion into ... greater ease. And since this sophisticated scope ...
Indications For Usage: , Thoracic surgery. , Broncho-spirometry. , Thoracoscopies. , Differential or selective lung ventilation. , Lung Lavage. ...
... double lumen tube made of silicone rubber with ... to the characteristics of silicone rubber, Silbronco is ... insertion. Furthermore, the tube will not soften like ... term surgery., ,Silbronco is also especially useful ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |